Detection of COVID-19 Using Breath Analysis - Validation Study

NCT04602949 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2558

Last updated 2023-05-16

No results posted yet for this study

Summary

DETECTION OF THE 2019 NOVEL CORONAVIRUS (SARS-CoV-2) USING BREATH ANALYSIS- VALIDATION STUDY

Conditions

  • Covid19

Interventions

DIAGNOSTIC_TEST

Breath Biopsy Analysis

Analysis of a single breath Biopsy

Sponsors & Collaborators

  • Scentech Medical Technologies Ltd

    lead INDUSTRY

Principal Investigators

  • Natalie Dror, PhD · Scentech Medical Technologies Ltd

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-11-12
Primary Completion
2022-05-28
Completion
2023-01-18

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04602949 on ClinicalTrials.gov